Versus Systems Inc. - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on July 15, 2022, reports a material definitive agreement entered into by Versus Systems Inc. on July 13, 2022. The filing details a registered direct offering and a concurrent private placement of warrants to an institutional investor.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2,155,195.50 from the sale of securities.
- Securities Issued: 2,100,000 Common Shares and 2,045,000 Pre-funded Warrants.
- Purchase Price: $0.52 per Common Share and $0.5199 per Pre-funded Warrant.
- Placement Agent Fees: 8% cash fee of aggregate proceeds plus warrants to purchase 331,600 Common Shares.
- Concurrent Private Placement: Sale of 6,217,500 Common Warrants exercisable at $0.52 per share.
Note: The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity as it focuses solely on the capital raise transaction.
Material Changes and Transaction Terms
The primary material change is the dilution of existing shareholders due to the issuance of new shares and warrants. Key terms include:
- Pre-funded Warrants: Immediately exercisable at $0.0001 per share; subject to beneficial ownership limitations (4.99% or 9.99%).
- Common Warrants: Exercisable six months after issuance with a 5.5-year term; exercisable on a cashless basis if no effective registration statement exists.
- Lock-up Period: The Company agreed not to issue or announce the issuance of Common Shares or equivalents for 30 calendar days following the closing of the Offering.
Outlook, Risks, and Management Commentary
The Company utilized an effective shelf registration statement (Form F-3) filed in March 2022 to facilitate this offering. The proceeds are intended to support the Company's operations, though specific allocation details are not provided in this filing. Risks associated with the transaction include potential dilution to existing shareholders and the impact of the beneficial ownership limitations on the exercisability of warrants.
Investor Verification Checklist
- Verify the final closing date and net proceeds after deducting placement agent fees and offering expenses.
- Review the full text of the Securities Purchase Agreement (Exhibit 99.2) for specific covenants and redemption rights.
- Confirm the impact of the 6,217,500 Common Warrants on future share count and potential dilution.
- Check subsequent filings for the actual use of proceeds and any changes to the Company's liquidity position.